Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Abrdn Global Dynamic Dividend Fund | AGD | Sep 19, 2024 | 10.35 | +0.88 |
Abrdn Global Premier Properties Fund | AWP | Sep 19, 2024 | 4.50 | -0.66 |
Abrdn Healthcare Opportunities Fund Shares Of Beneficial Int | THQ | Sep 19, 2024 | 21.96 | +0.18 |
Abrdn Life Sciences Investors Shares Of Beneficial Interest | HQL | Sep 19, 2024 | 15.54 | +1.17 |
Abrdn National Municipal Income Fund | VFL | Sep 19, 2024 | 11.30 | -0.26 |
Abrdn Total Dynamic Dividend Fund | AOD | Sep 19, 2024 | 8.98 | +1.01 |
Abrdn World Healthcare Fund Shares Of Beneficial Interest | THW | Sep 19, 2024 | 13.33 | +0.30 |
Absci | ABSI | Sep 19, 2024 | 4.31 | +8.29 |
ABVC Biopharma | ABVC | Sep 19, 2024 | 0.66 | +0.18 |
Ac Immune SA | ACIU | Sep 19, 2024 | 3.69 | +1.65 |
Acacia Research | ACTG | Sep 19, 2024 | 4.68 | -0.21 |
Academy Sports and Outdoors | ASO | Sep 19, 2024 | 61.83 | -1.47 |
Acadia Healthcare | ACHC | Sep 19, 2024 | 77.44 | -0.64 |
Acadia Pharmaceuticals | ACAD | Sep 19, 2024 | 16.42 | +0.55 |
Acadia Realty Trust | AKR | Sep 19, 2024 | 22.68 | +0.22 |
Acasti Pharma A | ACST | Sep 19, 2024 | 2.78 | +2.21 |
Accel Entertainment | ACEL | Sep 19, 2024 | 12.09 | +1.09 |
Accelerate Diagnostics | AXDX | Sep 19, 2024 | 1.47 | 0.00 |
Accenture A | ACN | Sep 19, 2024 | 335.24 | -0.28 |
Acco Brands | ACCO | Sep 19, 2024 | 5.46 | +1.49 |
Accolade | ACCD | Sep 19, 2024 | 4.19 | +0.24 |
Accuray | ARAY | Sep 19, 2024 | 1.90 | -0.52 |
Acelyrin | SLRN | Sep 19, 2024 | 5.30 | +15.22 |
Achieve Life Sciences | ACHV | Sep 19, 2024 | 4.56 | +3.64 |
Achilles Therapeutics ADR | ACHL | Sep 19, 2024 | 0.94 | +32.39 |
ACI Worldwide | ACIW | Sep 19, 2024 | 49.46 | +0.61 |
Aclarion | ACON | Sep 19, 2024 | 0.19 | +5.11 |
Aclaris Therapeutics | ACRS | Sep 19, 2024 | 1.21 | +3.42 |
ACM Research A | ACMR | Sep 19, 2024 | 17.48 | +5.72 |
Acme United | ACU | Sep 19, 2024 | 42.64 | +2.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.